Instituut voor Tropische Geneeskunde
0410.057.701 · rovalta.com · 27/09/2026
ACTIVE
Instituut voor Tropische Geneeskunde
Financial year 2025 · Closed on 31/12/2025
Net result1,4 M €-23,4 %over 1 year
Revenue21,1 M €+2,8 %over 1 year
Equity36,2 M €+3,9 %over 1 year
Workforce454,9 ETP+0,4 %over 1 year
Overview
Identity
Source · BCE/KBOInstituut voor Tropische Geneeskunde is a Public utility foundation incorporated in 1931. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Antwerpen. It employs on average 454,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0410.057.701
- Incorporation
- 31/03/1931
- Legal form
- Public utility foundation
- Registered office
- Nationalestraat 155
2000 Antwerpen · FlandreSee on map - Latest accounts
- 31/12/2025
- Average workforce
- 454,9 ETP
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue
Financials
Source · NBB, 14 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 21,1 M € | +2.8% | 20,5 M € | +3.1% | 19,9 M € | +9.2% | 18,2 M € | +11.4% | 16,3 M € |
| EBITDA | 3,5 M € | +32.5% | 2,6 M € | +702% | -437,6 k € | -128% | 1,5 M € | -46.5% | 2,9 M € |
| Operating result | 2,1 M € | +33.8% | 1,6 M € | +199% | -1,6 M € | -582% | 333,7 k € | -82.0% | 1,9 M € |
| Net result | 1,4 M € | -23.4% | 1,9 M € | +216% | -1,6 M € | -443% | 475,9 k € | -71.1% | 1,6 M € |
| Balance sheet | |||||||||
| Equity | 36,2 M € | +3.9% | 34,9 M € | +19.0% | 29,3 M € | -5.6% | 31 M € | +7.1% | 29 M € |
| Total assets | 68,1 M € | -1.3% | 69 M € | +2.8% | 67,2 M € | -0.2% | 67,3 M € | +4.3% | 64,6 M € |
| Cash | 28,7 M € | +0.7% | 28,5 M € | -4.1% | 29,7 M € | +8.4% | 27,4 M € | +2.6% | 26,7 M € |
| Debts | 30,5 M € | -7.6% | 33 M € | -8.5% | 36,1 M € | +6.2% | 34 M € | +1.7% | 33,4 M € |
| Other | |||||||||
| Workforce | 454,9 ETP | +0.4% | 453,0 ETP | +1.4% | 446,8 ETP | +2.4% | 436,4 ETP | +9.0% | 400,5 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
between 50 M€ and 100 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/202513 active · 59 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ann Adriaensen | Mandate | 00 | |
Ann Aerts | Mandate | ||
Ann Peters | Mandate | ||
Christel Van Geet | Mandate | 00 | |
Herwig Leirs | Mandate | 0 | |
Inge Basteleurs | Mandate | ||
Johan Bury | Mandate | ||
Luc Broos | Mandate | ||
Özge Tunçalp | Mandate | ||
Roel Coutinho | Mandate | ||
Stefaan Van der Borght | Mandate | ||
Steven Serneels | Mandate | 0 | |
Sunangal Ajit Shetty | Mandate |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Marc-Alain Widdowson | Director | since 12/08/2019 | |
Patricia Supply | Director | since 21/01/2019 | |
Bruno VAN DER PLUIJM | Director | since 19/10/2016 | 000 |
Herman VAN GOETHEM | Vice-chairman of the board of directors | since 19/10/2016 | 000 |
Other companies at this address
Nationalestraat 155 2000 Antwerpen| Company | CBE no. |
|---|---|
| 0472.859.855 | |
Metropical● Active | 0410.267.141 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/05/2026 | 10/06/2025 | 15/05/2024 | 22/05/2023 | 11/05/2022 | 03/05/2021 |
| General meeting | 23/03/2026 | 24/03/2025 | 25/03/2024 | 29/03/2023 | 28/03/2022 | 29/03/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 23/03/2026 | 07/05/2026 | Dutch | |
| Full model | 31/12/2024 | 24/03/2025 | 10/06/2025 | Dutch | |
| Full model | 31/12/2023 | 25/03/2024 | 15/05/2024 | Dutch | |
| Full model | 31/12/2022 | 29/03/2023 | 22/05/2023 | Dutch | |
| Full model | 31/12/2021 | 28/03/2022 | 11/05/2022 | Dutch | |
| Full model | 31/12/2020 | 29/03/2021 | 03/05/2021 | Dutch | |
| Full model | 31/12/2019 | 23/03/2020 | 30/04/2020 | Dutch | |
| Full model | 31/12/2018 | 25/03/2019 | 26/11/2019 | Dutch | |
| Full model | 31/12/2017 | 28/03/2018 | 21/06/2018 | Dutch | |
| Full modelCorrection | 31/12/2016 | 29/03/2017 | 10/11/2017 | Dutch | |
| Full model | 31/12/2016 | 29/03/2017 | 30/08/2017 | Dutch | |
| Full model | 31/12/2015 | 25/05/2016 | 06/07/2016 | Dutch | |
| Full model | 31/12/2014 | 01/06/2015 | 26/10/2015 | Dutch | |
| Full model | 31/12/2013 | 28/05/2014 | 26/09/2014 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 50 M€ and 100 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/202513 active · 59 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ann Adriaensen | Mandate | 00 | |
Ann Aerts | Mandate | ||
Ann Peters | Mandate | ||
Christel Van Geet | Mandate | 00 | |
Herwig Leirs | Mandate | 0 | |
Inge Basteleurs | Mandate | ||
Johan Bury | Mandate | ||
Luc Broos | Mandate | ||
Özge Tunçalp | Mandate | ||
Roel Coutinho | Mandate | ||
Stefaan Van der Borght | Mandate | ||
Steven Serneels | Mandate | 0 | |
Sunangal Ajit Shetty | Mandate |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Marc-Alain Widdowson | Director | since 12/08/2019 | |
Patricia Supply | Director | since 21/01/2019 | |
Bruno VAN DER PLUIJM | Director | since 19/10/2016 | 000 |
Herman VAN GOETHEM | Vice-chairman of the board of directors | since 19/10/2016 | 000 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates16/02/2026ONTSLAGEN - BENOEMINGEN
- Other13/02/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - DOEL
- Mandates05/02/2025ONTSLAGEN - BENOEMINGEN
- Mandates13/12/2023ONTSLAGEN - BENOEMINGEN
- Other12/07/2023BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates02/05/2023ONTSLAGEN - BENOEMINGEN
- Mandates24/03/2021ONTSLAGEN - BENOEMINGEN
- Mandates20/09/2019ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,4 M €↓
- 15/12/2025nominationAnn Peters · algemeen beheerder (ambtshalve lid)
- 15/12/2025nominationÖzge Tunçalp Mingard · directeur (ambtshalve lid)
- 15/12/2025nominationAnn Adriaensen · bestuurder
- 15/12/2025nominationAnn Aerts · bestuurder
- 15/12/2025nominationInge Basteleurs · bestuurder
- 15/12/2025nominationLuc Broos · bestuurder
- 15/12/2025nominationJohan Bury · bestuurder
- 15/12/2025nominationRoeland Coutinho · bestuurder
- 15/12/2025nominationHerwig Leirs · bestuurder
- 15/12/2025nominationSteven Serneels · bestuurder
- 15/12/2025nominationSunangal Shetty · bestuurder
- 15/12/2025nominationStefaan Van der Borght · bestuurder
- 15/12/2025nominationChristel Van Geet · bestuurder
- 01/01/2025nominationÖzge Tunçalp Mingard · directeur en bestuurder
- 2024Annual accounts 20241,9 M €↑
- 2023Annual accounts 2023-1,6 M €↓
- 2023Name changeInstituut voor Tropische Geneeskunde
- 15/05/2023reconductionGert Van Leemput · commissaris
- 01/04/2023nominationLutgarde Lynen · directeur en bestuurder
- 21/01/2023nominationAnn Adriaensen · bestuurder
- 2022Annual accounts 2022475,9 k €↓
- 01/07/2022reconductionHerwig Leirs · bestuurder
- 01/07/2022reconductionStefaan Van der Borght · bestuurder
- 01/07/2022reconductionChristel Van Geet · bestuurder
- 01/07/2022reconductionSunangal Ajit Shetty · bestuurder
- 01/07/2022reconductionRoeland Coutinho · bestuurder
- 01/07/2022reconductionSteven Serneels · bestuurder
- 01/07/2022nominationAnn Aerts · bestuurder
- 01/07/2022nominationInge Basteleurs · bestuurder
- 01/07/2022nominationJohan Bury · bestuurder
- 01/07/2022nominationLuc Broos · bestuurder
- 2020Annual accounts 20201,6 M €↑
- 2019Annual accounts 2019351,9 k €↑
- 2018Annual accounts 2018-720,2 k €↑
- 2016Annual accounts 2016-1 M €↓
- 2014Annual accounts 2014807 k €
- 31/03/1931IncorporationPublic utility foundation
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Instituut voor Tropische GeneeskundeCurrent | accounts 2023 → 2025 · CBE, tracked since 27/09/2026 | Accounts 2025 · 2026-00105163 |
| Prins Leopold Instituut voor Tropische Geneeskunde | accounts 2022 | Accounts 2022 · 2023-00090695 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.